Transfusion medicine and hemostasis : clinical and laboratory aspects /
This new handbook in transfusion medicine and hemostasis aims to combine clinical and laboratory information from two fields which have high degrees of overlap into one concise, easy-to-use pocket book. This comprehensive reference guide will have the depth of information to be helpful to all physic...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Amsterdam ; Boston :
Elsevier,
�2009.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Part I. Blood banding and transfusion medicine
- Blood banding and transfusion medicine: the field, the discipline and the industry
- Brief history of blood transfusion
- Introduction to quality systems and quality management
- The role of the physician in the blood center-- The blood donor, donation process and technical aspects of blood collection
- Apheresis blood component collections
- Recipient-specific blood donations
- Adverse donor reactions
- Component preparation and manufacturing
- Serologic testing of donor products
- Overview of infectious disease testing
- HIV screening of donor products
- Hepatitis B screening of donor products
- Hepatitis C screening of donor products
- West Nile virus screening of donor products
- Syphilis, HTLV and Chagas testing of donor products
- Bacterial detection methods
- The role of the transfusion service physician
- Pretransfusion testing
- Antibody identification
- Direct antiglobulin test
- ABO and H blood group system
- Rh blood group system
- Kell and Kidd blood group systems
- MNS and Duffy blood group systems
- Lewis I and P blood group systems
- Other blood group systems, collections and antigens
- Red blood cells and related products
- Plasma products
- Platelet products
- Cryoprecipitate
- Granulocyte products
- Albumin and related products
- Human immunoglobulin preparations
- Rh immune globulin
- Irradiation of blood products
- Leukoreduction of blood products
- CMV-safe blood products
- Frozen blood products
- Washed blood products
- Volume-reduced products
- Neonatal and pediatric transfusion medicine
- Perinatal transfusion medicine
- Autoimmune hemolytic anemias
- Transfusion management in patients with hemoglobinopathies
- Transfusion of patients undergoing HPC and solid-organ transplantation
- Transfusion of HIV-positive patients
- Management of patients who refuse blood transfusion
- Platelet transfusion refractory patients
- Massive transfusion
- Perioperative blood management
- Adverse events and outcomes following transfusion: an overview
- Febrile non-hemolytic transfusion reactions
- Allergic, anaphylactoid and anaphylactic reactions
- Delayed hemolytic transfusion reactions
- Transfusion-associated circulatory overload
- Transfusion-related acute lung injury
- Septic transfusion reactions
- Metabolic, hypotensive and other acute reactions and complications
- Posttransfusion purpura
- Transfusion associated graft versus host disease
- Microchimerism
- Transfusion related immunomodulation
- Iron overload
- Transfusion transmitted diseases
- Overview of therapeutic apheresis
- Therapeutic plasma exchange
- Therapeutic erythrocytapheresis
- Therapeutic thrombocytapheresis
- Therapeutic leukapheresis
- Extracorporeal photopheresis
- LDL pheresis
- Immunoadsorption
- Therapeutic phlebotomy
- HPC products
- Tissue banking in the hospital setting.
- Part II. Coagulation
- Overview of the coagulation system
- Approach to the bleeding patient
- Congenital thrombocytopenia
- Neonatal alloimmune thrombocytopenia
- Acquired neonatal thrombocytopenia
- Bernard-Soulier syndrome and other GPIb-IX-V related receptor defects
- Glanzmann thrombasthenia
- Platelet storage-granule defects
- Failure to release and aspirin-like defects
- Acute (childhood) immune thrombocytopenic purpura
- Chronic immune thrombocytopenic purpura
- Drug-induced thrombocytopenia
- Heparin-induced thrombocytopenia
- autoimmune lymphoproliferative syndrome
- Hemolytic uremic syndrome
- Thrombotic thrombocytopenic purpura
- Antiphospholipid antibody syndrome
- von Willebrand disease
- Hemophilia A
- Hemophilia B
- Congenital disorders of fibrinogen
- Factor XIII, [alpha][2]-antiplasmin and plasminogen activator inhibitor-1 deficiencies
- Factor XI deficiency
- Factor VII deficiency
- Factor II, factor V and factor X deficiencies
- Bleeding disorders in pregnancy
- Vascular bleeding disorders
- Bleedings risks with liver disease
- Bleeding risks with vitamin K deficiency
- Bleeding risks with cardiac disease
- Bleeding risks with renal disease
- Bleeding risks in cancer
- Disseminate intravascular coagulopathy
- Acquired coagulation factor inhibitors
- Introduction to coagulation testing
- Prothrombin time and activated partial thromboplastin time
- Platelet count
- Global tests of primary hemostasis
- Platelet aggregation studies
- Laboratory diagnosis of genetic platelet function defects
- Laboratory diagnosis of acquired platelet function defects
- Laboratory diagnosis of immune thrombocytopenic purpura
- ADAMTS13 testing
- Laboratory diagnosis of heparin-induced thrombocytopenia
- Molecular biology of von Willebrand disease
- Laboratory diagnosis of inherited von Willebrand disease
- Laboratory diagnosis of acquired von Willebrand syndrome
- Laboratory assessment of treatment of von Willebrand disease
- Coagulation factor testing
- Mixing studies
- Specific factor inhibitor testing
- Laboratory diagnosis of dysfibrinogenemia and afibrinogenemia
- Laboratory assessment of fibrinolysis
- General overview of the hypercoagulable state
- Antithrombin testing
- Proteins C, S and Z testing
- Activated protein C resistance and factor V Leiden testing
- Prothrombin gene mutation testing
- Laboratory diagnosis of hyperhomocysteinemia
- Laboratory diagnosis of lupus anticoagulant and antiphospholipid antibodies
- Lipoproteins(a) testing
- Laboratory diagnosis of factor level abnormalities associated with thrombosis
- Laboratory management of DIC
- Laboratory support for heparin monitoring
- Laboratory support for Warfarin monitoring
- Prothrombin complex concentrates
- von Willebrand factor concentrates
- Factor VIII concentrates
- Factor IX concentrates
- Factor VII concentrates
- Antithrombin concentrates
- Protein C concentrates.